Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer

Tumor Response to Pemetrexed Disodium in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Enrolled in Clinical Trial MCCRC-RC0524

NCT00898820 ·Status: COMPLETED

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

NCT05564377 ·Status: RECRUITING ·Phase: PHASE2

Phase I/II Study of Lenalidomide Plus Pembrolizumab in Patients With Solid Tumors With Expansion in Non-small Cell Lung Cancer

NCT02963610 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Safety and Efficacy Study of GEN1046 as a Single Agent or in Combination With Pembrolizumab for Treatment of Recurrent (Non-small Cell) Lung Cancer

NCT05117242 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Phase II Trial of Sequential Consolidation With Pembrolizumab Followed by Nab-paclitaxel

NCT02684461 ·Status: COMPLETED ·Phase: PHASE2

Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases

NCT05064280 ·Status: RECRUITING ·Phase: PHASE2

Study of Combined Ionizing Radiation and Ipilimumab in Metastatic Non-small Cell Lung Cancer (NSCLC)

NCT02221739 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

MYLUNG Consortium Study Protocol 2

NCT05644808 ·Status: ACTIVE_NOT_RECRUITING

Association Between Circulating Immune Cells and the Tumor Immune Contexture in Resectable Non-small Cell Lung Cancer

NCT02551211 ·Status: TERMINATED ·Phase: NA

A Phase IIA Study of MK0457 in Patients With Cancer of the Lung (0457-006)

NCT00290550 ·Status: TERMINATED ·Phase: PHASE2

Phase I/II Study of Nivolumab and Ipilimumab Combined With Nintedanib in Non Small Cell Lung Cancer

NCT03377023 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Patient-derived Organoid Drug Sensitivity Guided Treatment for Drug-resistant Recurrent Non-Small Cell Lung Cancer

NCT06406608 ·Status: RECRUITING ·Phase: NA

PD-1 Antibody in Addition to BACE in Patients With NSCLC: A Randomised Controlled Trial

NCT05605613 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Identification by Microarrays of the Risks of Metastatic Relapse, Toxicity and Resistance to Adjuvant Chemotherapy in Completely Resected Non-small Cell Lung Cancer

NCT02075957 ·Status: UNKNOWN

A Phase 1b/2 Study of AMG 655 in Combination With Paclitaxel and Carboplatin for the First-Line Treatment of Advanced Non-Small Cell Lung Cancer

NCT00534027 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Genetic Predictors of Benefit to Pembrolizumab

NCT02710396 ·Status: TERMINATED ·Phase: PHASE2

Local Consolidative Radiotherapy for Oligoprogressive in Non-small Cell Lung Carcinoma

NCT04485026 ·Status: WITHDRAWN ·Phase: PHASE2

Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Advanced Stage Non-small Cell Lung Cancer Patients Who Are PD-L1 Negative

NCT04929041 ·Status: SUSPENDED ·Phase: PHASE2/PHASE3

Testing the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus Pembrolizumab) Against the Usual Treatment for Advanced Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)

NCT05096663 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3

Effect of Pembrolizumab With or Without Carboplatin and Paclitaxel on Immune Response in Patients With Recurrent or Stage IIIB-IV Non-small Cell Lung Cancer

NCT02581943 ·Status: COMPLETED ·Phase: PHASE2

Biomarkers in Predicting Treatment Response in Samples From Patients With Early-Stage Non-Small Cell Lung Cancer Previously Treated With Adjuvant Chemotherapy

NCT01595074 ·Status: NOT_YET_RECRUITING

Randomized Study of Maintenance Therapy With MGN1703 in Patients With SCLC

NCT02200081 ·Status: COMPLETED ·Phase: PHASE2

Pembrolizumab vs Topotecan in Patients With Small Cell Lung Cancer

NCT02963090 ·Status: TERMINATED ·Phase: PHASE2

Phase 2 Study of MPDL3280A Combined With CDX-1401 in NY-ESO 1 (+) IIIB, IV or Recurrent Non-Small Cell Lung Cancer

NCT02495636 ·Status: WITHDRAWN ·Phase: PHASE2

Bronchial Artery Infusion of Gemcitabine in Treating Patients With Recurrent or Progressive Non-Small Cell Lung Cancer

NCT00619021 ·Status: TERMINATED ·Phase: PHASE1